Profund Advisors LLC cut its stake in shares of Teleflex Incorporated (NYSE:TFX) by 7.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 5,667 shares of the medical technology company’s stock after selling 473 shares during the period. Profund Advisors LLC’s holdings in Teleflex were worth $1,410,000 at the end of the most recent reporting period.
Other large investors also recently bought and sold shares of the company. Coldstream Capital Management Inc. acquired a new position in shares of Teleflex during the 3rd quarter worth $226,000. Quantitative Systematic Strategies LLC acquired a new position in shares of Teleflex during the 4th quarter worth $228,000. Checchi Capital Advisers LLC acquired a new position in shares of Teleflex during the 4th quarter worth $230,000. Lourd Capital LLC acquired a new position in shares of Teleflex during the 4th quarter worth $266,000. Finally, Independence Advisors LLC acquired a new position in shares of Teleflex during the 4th quarter worth $276,000. 90.75% of the stock is currently owned by institutional investors and hedge funds.
TFX has been the topic of a number of recent analyst reports. Deutsche Bank cut shares of Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price target on the stock. in a research note on Tuesday, November 14th. ValuEngine lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Stephens reiterated a “buy” rating and issued a $300.00 price objective on shares of Teleflex in a research report on Thursday, January 18th. Finally, Leerink Swann reiterated a “buy” rating and issued a $321.00 price objective (up from $307.00) on shares of Teleflex in a research report on Tuesday, January 30th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company’s stock. Teleflex currently has an average rating of “Hold” and a consensus target price of $281.56.
Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $2.44 EPS for the quarter, topping the consensus estimate of $2.40 by $0.04. Teleflex had a net margin of 7.11% and a return on equity of 16.46%. The business had revenue of $595.10 million for the quarter, compared to analyst estimates of $601.17 million. During the same period in the previous year, the firm earned $2.13 EPS. The business’s revenue for the quarter was up 15.8% compared to the same quarter last year. analysts anticipate that Teleflex Incorporated will post 9.68 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Friday, March 2nd will be issued a $0.34 dividend. The ex-dividend date is Thursday, March 1st. This represents a $1.36 dividend on an annualized basis and a yield of 0.51%. Teleflex’s dividend payout ratio (DPR) is 41.59%.
In other Teleflex news, Director George Babich, Jr. sold 2,500 shares of the company’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $283.11, for a total value of $707,775.00. Following the transaction, the director now directly owns 9,581 shares in the company, valued at approximately $2,712,476.91. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP John Deren sold 1,359 shares of the company’s stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of $255.67, for a total transaction of $347,455.53. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,759 shares of company stock worth $3,089,211. 2.39% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: “Teleflex Incorporated (TFX) Stake Decreased by Profund Advisors LLC” was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://sportsperspectives.com/2018/03/12/teleflex-incorporated-tfx-stake-decreased-by-profund-advisors-llc.html.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.